Mad Money w/ Jim Cramer 2/4/26

Summary

Mad Money w/ Jim Cramer – February 5, 2026: Episode Summary

Overview

In this episode, Jim Cramer takes listeners through a volatile day on Wall Street, examining the sharp moves in both "hot" tech stocks and more traditional sectors. The episode features signature segments: Cramer’s market commentary, an in-depth interview with Novo Nordisk’s CEO on the GLP-1 drug race, a discussion with Banco Santander’s Executive Chair on the bank's rapid US growth, a conversation with Take-Two Interactive’s CEO about the future of gaming in an AI world, followed by the enthuastic “Lightning Round,” and a closing reflection on the impact of AI on the software industry.

---

Market Commentary & Investment Insights

Key Points:

• Cramer warns about the dangers of chasing "parabolic" stocks that soared and are now crashing.
• He notes the resilience and value in sectors like industrials, health care, retail, and AI adopters over speculative tech and unprofitable futuristic companies.
• Old staples (food, pharma, industrials, banks) are outperforming while former tech darlings underperform amid AI disruption.
• Urges listeners to maintain diversification; overexposure to high-beta tech or speculative sectors could be catastrophic in current volatility.

Quotes:

• “There is a reason I always hesitate to recommend the hottest stocks in the market…the ones with the parabolic moves…days where you can lose so much money…” (03:03)
• "If you despise diversification, I got some real bad news for you. If this volatility keeps up... you're going to get smashed..." (08:58)

Timestamps:

• [01:42] – Cramer’s market intro, caution on hot stocks
• [03:00–09:40] – In-depth on sector rotation, AI’s influence, tech underperformance, and the need for diversification

---

Interview: Novo Nordisk CEO, Mike Dewstar – GLP-1 Drug Competition

Key Topics:

• Novo Nordisk’s GLP-1 (semaglutide/Ozempic/WeGovy) performance and new pill form launch.
• Price reductions impacting short-term sales guidance due to increased competition from Eli Lilly.
• Cramer’s pushback on the company’s conservative outlook, arguing Novo’s innovations and supply chain readiness position it well.
• Dewstar’s focus on patient needs, innovation, and the adoption rate of the new pill, which uses unique technology for high efficacy.

Notable Quotes:

• “The pill is, has had a phenomenal uptick, Jim. It has been probably one of the best...pharma launches…” – Mike Dewstar [14:42]
• “We have now on a weekly basis 50,000 prescriptions coming in...170,000 Americans are on the pill in four weeks.” – Mike Dewstar [14:49]
• “They will take basically the higher effective product. And…with diabetic patients, [dosing regimen] is a non-issue.” – Mike Dewstar [18:32]
• “Internally, Jim, I say this is a marathon and not a sprint. Even though every single day we got a sprint on our daily activities. The war and the battles are won in a marathon passion and not in a sprint.” – Mike Dewstar [19:58]
• “We feel very confident from a supply point of view, which is, unfortunately, the issue we ran into with the injection. We are very comfortable with the pill…” – Mike Dewstar [21:38]

Timestamps:

• [13:26] – Cramer introduces Novo Nordisk segment
• [14:11–22:45] – Full interview with Mike Dewstar, covering competitive positioning, drug efficacy, business guidance, and market strategy

---

Interview: Ana Botín, Executive Chair of Banco Santander – Banking Growth

Key Topics:

• Banco Santander’s stock has surged 142% in 12 months, focusing on profitability and growth.
• Acquisition of Webster Financial to strengthen footprint in wealthy Northeastern US markets.
• Strategic discussion on why Santander left Poland and doubled down in the UK and US.
• Unique approach: serving both mass-market and wealthy customers—a contrast with other global banks.
• Resilience of US consumer, especially on auto loan credit quality, and positive outlook for 2026 in Europe and the Americas.

Notable Quotes:

• “Profitability, being the most profitable bank in each one of our businesses and geographies is our big goal. And obviously we also want to grow.” – Ana Botín [25:47]
• "In 2025…we grew 8 million customers…now at 180 million customers." – Ana Botín [26:29]
• “Webster and Santander will become the fifth largest bank in its footprint… and will have an 8% market share…combined will get to 18% return on tangible equity by 28.” – Ana Botín [27:30]
• “The Santander world... overall looks better in 26 than it did in 25…solid growth, not great, but solid growth.” – Ana Botín [32:00]

Timestamps:

• [24:04] – Cramer introduces Banco Santander segment
• [25:19–33:04] – Interview with Ana Botín on profitability, US expansion, strategy, and global economic outlook

---

Interview: Strauss Zelnick, CEO of Take-Two Interactive – AI & The Future of Gaming

Key Topics:

• Addressing concerns about Google’s Project Genie and AI-generated video games disrupting traditional studios.
• Zelnick asserts that Take-Two’s expertise and IP superiority make them AI beneficiaries, not victims.
• Revelation of AI and machine learning integration at Take-Two; hundreds of AI projects ongoing.
• Strong performance in mobile gaming and perennial franchises like NBA 2K and Grand Theft Auto (GTA).
• Anticipation and strategy for the November 2026 GTA 6 launch, expected to energize both game sales and console upgrades.

Notable Quotes:

• “Our business has availed itself with machine learning and artificial intelligence since the beginning...Hundreds of AI projects going on now.” – Strauss Zelnick [35:16]
• “If you keep doing great stuff, the work has to get better and better. Visual Concepts… just sets the bar higher and higher every year. We're up 30% year over year.” – Strauss Zelnick [36:37]
• “I think there's going to be [a console] upgrade cycle. That's much better than say the co-pilot up.” – Jim Cramer [39:33]

Timestamps:

• [33:26] – Cramer introduces Take-Two Interactive segment
• [34:08–39:49] – Interview with Strauss Zelnick

---

Lightning Round – Rapid-Fire Stock Picks

Key Points:

• Cramer gives quick buy/hold/sell opinions on viewer-caller stocks:
  • Gold miners (Agnico Eagle, Newmont): favorable outlook due to gold price/costs.
  • Biocryst Pharmaceuticals (BCRS): negative, “just stay away from that.”
  • NXT (Next Power): positive, “Just go buy it.”
  • SkyWest Incorporated: buy United and FedEx instead.
  • Synchrony Financial: prefers Capital One.
  • EOS Energy Enterprises: too speculative, “year of magical thinking” stock—don’t touch.
• Emphasizes disciplined investing and skepticism on “magical” speculative names.

Memorable Moment:

• “You don't want to be the first man on the sun. I know what that's like.” – Cramer [10:04]

Timestamps:

• [40:31–44:10] – Lightning Round

---

Closing Essay: The AI Coding Apocalypse

Key Points:

• Cramer reflects on the history of lucrative Wall Street jobs: from investment banking to private equity to coding/tech startups.
• The new disruptor: AI platforms that can write code, threatening the business model of enterprise software and diminishing the value of coders.
• Firms like Anthropic launching AI tools for business functions, leading to rapid “multiple compression” in software stocks.
• Some software firms will survive and adapt, but the golden era of infinite growth and high multiples for the entire sector is likely over.

Notable Quote:

• “With AI you don't need programmers because these platforms can write code better than humans…It could be a coding apocalypse. And that's why all the enterprise software stocks are coming back to earth.” – Jim Cramer [44:25]

Timestamps:

• [44:25–48:20] – Closing commentary on AI’s impact on coders and software stocks

---

Episode Highlights / Notable Quotes (Quick Reference)

• On diversification: “…if you despise diversification, I got some real bad news for you. If this volatility keeps up…you’re going to get smashed…” (08:58)
• On Novo Nordisk’s pill: “[The pill is] probably one of the best, if not the best pharma launches…170,000 Americans are on the pill in four weeks time.” – Mike Dewstar (14:49)
• On AI and coders: “…With AI you don't need programmers…It could be a coding apocalypse.” (44:25)
• On gaming and AI: “Our business has availed itself with machine learning and artificial intelligence since the beginning…Hundreds of AI projects going on now…” – Strauss Zelnick (35:16)
• On Santander’s strategy: “Profitability, being the most profitable bank in each one of our businesses and geographies is our big goal. And obviously we also want to grow.” – Ana Botín (25:47)

---

Timestamps for Major Segments

• [01:42] Market commentary opens
• [13:26] Novo Nordisk CEO interview
• [24:04] Banco Santander CEO interview
• [33:26] Take-Two Interactive CEO interview
• [40:31] Lightning Round
• [44:25] “The AI Coding Apocalypse” closing essay

---

Tone & Language

• Energetic, urgent, and sometimes humorous (“first man on the sun”, “flying cars”, “magical thinking stocks”)
• Cramer’s direct, no-nonsense style, with an undercurrent of caution in the current market climate

---

Summary Use

This summary provides a comprehensive and engaging overview of the episode, organized by segment and subject, capturing Cramer’s tone, notable guest insights, and practical timestamps for easy reference. Even without listening, readers will grasp the episode’s flow, highlights, and actionable insights on markets, key sectors, and major companies discussed.

Transcript

[Homes.com Narrator]

Homes.com knows that when it comes to home shopping, it's never just about the house or condo, it's about the home. And what makes a home is more than just the house or property, it's the location and neighborhood. If you have kids, it's also schools, nearby, parks and transportation options. That's why homes.com goes above and beyond to bring home shoppers the in depth information they need to find the right home. And when I say in depth, I'm talking deep. Each listing features comprehensive information about the neighborhood, complete with a video guide. They also have details about local schools with test scores, state rankings and student to teacher ratio. They even have an agent directory with the sales history of each agent. So when it comes to finding a home, not just a house, this is everything you need to know all in one place. Homes.com, we've done your homework.

[Jim Cramer]

Hey Fidelity, what's it cost to invest.

[Various Advertisers/Voiceover]

With the Fidelity app?

[Jim Cramer]

Start with as little as $1 with no account fees or trade commission. US stocks and ETFs. Hm, that's music to my ears. I can only talk.

[Strauss Zelnick]

Investing involves risk, including risk of loss. Zero Account fees apply to retail brokerage accounts only Sell order assessment fee not included. A limited number of ETFs are subject to a transaction based service fee of $100. See full list of Fidelity.com commissions Fidelity Brokerage Services LLC Member NYSE, SIPC.

[Jim Cramer]

Hey, I'm Kramer. Welcome to Mad Money. Welcome to Kramerica. Other people want to make friends. I just want to make you money. My job is not just to entertain, but to educate and teach you. So call me at 1-800-743-CBC. You can tweet me at Jim Cramer. There is a reason I always hesitate to recommend the hottest stocks in the market, the ones with the parabolic moves, the monstrous one day gains. Why? Because days like today, that's why days where you can lose so much money in the high flyers, more than you made when they were going up, that it just takes your breath away. Sure, once again, the averages masked some of the pain, with the Dow gaining 260 points. S&P shed 0.51%. Nasdaq did tumble 1.51%, though we had plenty of winners today, mainly the stocks of companies that can improve their businesses, presumably by using artificial intelligence transports, industrials, retailers, restaurants, health care. On every single conference call they talk about how AI is saving them money or making them money or certainly making them more productive, even if in reality it's marginal or even fanciful or worse. Yes, chimerical. We have companies that were supposed to have their earnings hurt by the GOP Dash 1. Companies like Campbell's or PepsiCo or Smuck or even craft hides that could benefit from AI. Their stocks are going much higher, as if the GOP somehow stopped working and we all got hungry for junk food. But then we have the chief maker of the GOP dash ones, Eli Lilly, soaring more than 10% as it rolls out trial after trial to see what these drugs can do beyond weight loss and diabetes. Things like alcohol and tobacco addiction. They can make the ATF obsolete. Louis got a joint venture with Nvidia where they're going to treat hard to treat going after hard to treat diseases. Hey, come on. With that kind of firepower, they'll develop a new line of forever people. Louis Gaines, also arch rival Novo Nordisk. Pain. It's not enough that President Trump wants to annex Greenland. Eli Lilly's constantly taking share from Danish Novo Nordisk. We've got Novo on tonight and you may actually want to sample some or at least consider the GOP Dash 1 pill form that they have where you have a momentary edge over Eli Lilly. Still use an injector there. But he's not alone. The irrepressible Johnson Johnson with the effervescent Merck and Amgen. They simply refuse to quit. Why not? Even after the runs they've had this year alone, their stocks are not expensive versus the rest of the market. These are old fashioned solid earners without the Tony Soprano overtones. The banks are crushing it when they say they're using artificial intelligence. Guess what? They really are. They're probably sampling the new anthropic product that can help their general counsels to keep some legal work in house rather than paying through the nose for outside counsel. Much to the chagrin of say, Thompson Reuters, which has a similar product but apparently not as good and much more expensive. The revolutionary anthropic can also write code for you if you ask it to measure your software systems versus say what the program says is the best is basically a knock off version of Gartner, which is why that stock's down a cool 37% since the beginning of the year. And the industrials, the old fashioned non data center industrials are looking like huge winners from AI even if we don't know yet whether they deserve it. These stocks are doing so well. Honeywell, Dover, Emerson, Wowzer can they run? But in reality, all they're really doing is catching up with the rest of the market. They are not expensive historically versus the S&P 500, which is how you evaluate these things. These winners are why you should be invested in individual stocks. Think of what they've done. They have earnings, they have dividends. They have. They're not that expensive at least versus Tech. They are delights with buybacks. They don't overpay the people with stock options. Plus during earnings season they can give you huge upside surprises. And their stocks are being rewarded this year. It's how the stock market was meant to work. It's how stocks work before tech took over and made itself the only investable part of the market. That's over too. I don't know if there's still huge amount of hope for tech. There's some. Obviously tech's a good part of the market. It's just that many of these stocks suddenly aren't worth as much as we thought. Some of that's because the whole enterprise software cohort is going out of style thanks to AI. More on that later. On the other hand, we have lots of companies that don't make any money and got infected by speculation. These were the year of magical thinking stocks I told you to avoid. The ones I warned you off back in October. We don't want to own quantum stocks anymore because they're 2030 science projects. Flying cars. Hey, Boeing's got a flying car. If you want it, just go on Boeing. Will you have anything to do with batteries? No, don't. No, thank you. Don't you know the President likes fossil fuels? Get with the program and sell those bad boys. Oh, and it gets worse. Nuclear power? Sure, the President wants it. I don't blame him. Long term, nuclear is the best way to generate clean energy and keep all these data centers running. But let's face facts. We're building up Potemkin Village Gemini of nuclear shells that won't be ready until 2032 with the earliest radio. Probably later than that. You want to wait in oclo? Be my guess. I'd rather wait in Oreo, which is of course made by Mondelez and they had a not so hot quarter. Oreos are safer. Can we spare Iran? That's Irene. Can we not only be. I mean, those could be halved and then halved again and still be outrageously expensive. Well, how about all those crypto derivatives that people fall over? The immersive bitcoins, the strategies, AKA microstrategies There, Port. I'm saving the best for last. The overvalued companies that are made up of really smart coders when we don't need coders that much anymore. AI is getting so powerful that this entire profession ain't what it used to be. All the coders turned out by Stanford these last couple decades. They were. They were so envious of. They are about to have a hard time. For the first time in 30 years, I can admit that Stanford was my safety school when I applied to Harvard. Didn't need it. We know some tech companies can transcend the morass. Alphabet, the parent company of Google, report a stunning quarter this Evening with their Gemini 3 platform already racking up an astounding 750 million monthly average users. But any gains could be a little muted there because they are spending about 175, 185 billion on capital goods. Wall street was only looking for 115 billion. That's a big chunk of money, by the way. A lot of could be headed to Google favorite Broadcom, but it's a $4 trillion company. I'm not sweating the program. Gemini is winning the race, at least on the consumer side. So I think it's worth every penny to spend. Remember Google spent to defeat Bing and all other commerce. I think it's doing it again. It worked. Oh, and how about buying the hottest of the hot? If you watch sandisk or Seagate or Western Digital, even Micron, you know what it's like to fly too close to the sun. In fact, does anyone here remember the legendary Richard Pryor? He knew what it was like to own sandisk. It is like being the first man on the sun. I had to do it. Never fear though. There are solid tech companies that make a lot of money, do big buybacks and even offer dividends. They can still go higher, but they're paying penance right now for the stock excess of their brethren. When they're done cooling off, these are going to come back. However, their future rallies will be driven by higher earnings, not higher price earnings multiples or higher price sales multiples. They have to start making a lot of money now. There's something good going on here. The speculators, the bitcoiners and all their somewhat bogus derivatives which were supposed to be used as currency, probably never will. The blockchainers, the quantum computers, they are supposed to. Yet they're going to go away. The phantasmagorical electric Kool Aid acid test cars, they're all shrinking. I don't want their owners to go with them. If you own these, it's still not too late. But if you're not willing to diversify into a Kimberly Clark, if you can't take owning a Vartis or General. If Federal Express is too much of a drag, it may be too late for you. If so, the bottom line, let me give it to you. If you despise diversification, I got some real bad news for you. If this volatility keeps up, volatility being a code name for getting the bejesus kicked out of you, and you stay undiversified, then you're going to get smashed by a Bitcoin derivative. One that guarantees you the full faith and credit of an analyst or a hedge fund manager who spouts their virtue on every media outlet. I say these things should never have been born. For lots of these. Incredibly, it's still not too late to sell. Sell, sell, sell. I want to go to Joe in New York. Joe.

[Caller/Viewer]

Mr. Jim, thank you for your insight. Much appreciated.

[Jim Cramer]

Thank you, Joe. What's up?

[Caller/Viewer]

I'm looking at a $300 stock that's now $55. I've been buying on the way down and crying since November. It's moving sideways. I want to know, do I put the moron position on or has my circle flatlined?

[Jim Cramer]

Circle Internet. Yeah, no, I don't really want to own that. Look, maybe it bounces and then you can say goodbye. But that one. That one flew way too close to the sun. You don't want to be the first man on the sun. I know what that's like. Okay, look, you have to stay diversified while this rotation plays out. It might be painful to see tech go down, but we'll pick among the good ones when they're done. Is now the time to buy the dip in the shares of Novo Nordisk? I'm sitting down with the company's top brass. See where one of the leaders in the gop. That's one space can go from here then. Banco Santander. Been on fire over the past couple of years and I'm learning more about the company's monster move higher with the CEO and a beat and race quarter wasn't enough to send shares and take to Interactive Hire today, but is now the time for investors to take a closer look at a video game developer? I'm sitting down with the company's top brands to find out, so stay with Kramer.

[Podcast Host/Announcer]

Don't miss a second of Mad Money. Follow imkramer on X. Have a question? Tweet Kramer Madmentions. Send Jim an email to madmoneynbc.com or give us a call at 1-800-743-CNBC. Miss something? Head to madmoney.cnbc.com.

[Commercial Voiceover]

Comcast Business helps retailers become seamlessly restocking, frictionless paying favorite shopping destinations. It's how nationwide restaurants become touchscreen ordering, quick serving eateries and how hospitals become the patient scanning data, managing healthcare facilities that we all depend on. With leading networking and connectivity, advanced cybersecurity and expert partnership, Comcast Business is powering the engine of modern business powering possibilities. Restrictions apply.

[Various Advertisers/Voiceover]

Hey there, I'm Kat. I'm a college athlete. I was diagnosed with ankylosing spondylitis which caused back pain and stiffness.

[Jim Cramer]

Every day with Cosentyx I'm able to stay active.

[Commercial Voiceover]

Cosentyx Secukinumab is prescribed for adults with active psoriatic arthritis, ankylosing spondylitis or non radiographic axial spondyloarthritis. Available in both IV infusion and self injection. Don't use if allergic to Cosentyx. Get checked for TB before starting. Increased risk of infections and lowered ability to fight them may occur like TB or other serious bacterial, fungal or viral infections. Some were fatal. Tell your doctor if you have an infection or symptoms like fevers, sweats, chills, muscle aches or cough, had a vaccine or planned to, or if IBD symptoms develop, develop or worsen serious allergic reactions and severe eczema like skin reactions may occur. Learn more at 1-844-cosentyx or cosentix.com move and feel better.

[Various Advertisers/Voiceover]

Ask a rheumatologist about Cosentyx.

[TurboTax Representative]

Taxes was feeling unwelcome. Now taxes is an open door literally to new TurboTax stores. Meet our experts in person.

[Various Advertisers/Voiceover]

Hi, welcome in.

[TurboTax Representative]

They're powered by smart tech and ready to do your taxes for you. Get real time updates while you go about your day. Confident your taxes are done right now, this is Taxes Intuit. TurboTax TurboTax store is opening soon. Real time updates only in iOS mobile app.

[Jim Cramer]

What went wrong at Novo Nordisk yesterday? The Danish drug baker behind Ozempic reported and the stock plunged nearly 15% for sinking another 6% today. While the quarter is fine. The guidance let's just say it was brutal. They're Talking about a 5% to 13% sales hit this year thanks to pricing pressures amid fierce competition for the GOP Dash 1 business, it seems Eli Lilly's eating their lunch, even if it is a lunch that has no taste. The never result of all GOP is so how bad is it exactly? Or Today we sat down with Mike Dewstar. He's the president and CEO of Novo. Norris, you got to look at this Mike, welcome back to Mad Money.

[Mike Dewstar]

Thank you very much for having me, Jim.

[Jim Cramer]

Okay, so I have to admit I was surprised at what you're forecasting and the reason I say that is because you have a very competitive set of of medicines versus Eli Lilly. You are obviously first, jeez, first mover in the pill, which is going to be very big. Your numbers are great for the pill already and yet you did not guide to a number that I would have expected. Given your edge over Eli Lilly, can you explain what happened?

[Mike Dewstar]

Of course. So the pill is, has had a phenomenal uptick, Jim. It has been probably one of the best, if not the best pharma launches, albeit on a short period of one month. We have now on a weekly basis 50,000 prescriptions coming in and that actually translates to 170,000Americans are on the pill in four weeks time. So, so this is better. And just to put it in perspective, Jim, this is two times better than when our competitors launch zeb bound or 15 times better than when we had our WeGovy injectable. So that is good. But of course the pill is a new business. What has happened is on our existing business, on semaglutide injectable Ozempic and we go V, we have been quite transparent that we have reduced the price in order for the volume uptake to happen in a much faster way than in the past. And of course when in a large base you reduce the price, you see the impact of that immediately in a given year, while the volume uptakes comes much more gradually throughout this year and of course much more into the following years.

[Jim Cramer]

Well, but Mike, I've got to tell you, Eli Lilly has not had a similar response. They are actually being able to make it up in price. I know typically as a business person it doesn't work like that, but it is working for Eli Lilly. So now I'm concerned that competitively you're losing some edge because they have taken share. Given your similar price structure, I'm trying to figure out how they could take share.

[Mike Dewstar]

So there's actually three things here that we need to separate them. There is the pill. Clearly we have the most efficacious weight dry weight reduction pill that there is. And I'm very optimistic and bullish on when they come with their pill and we have to battle this out. Then there's the injectable. On the injectable front, Jim, last time we spoke about, we did touch upon the fact that the world right now believes to appetite Lilly's product is the more efficacious drug out there at 20, 21% weight loss and semaglutide is at 15. So the preference share, there is no secret is on Lilly's side. But I also mentioned to you that we have a plan for that. Medicine is dosed differently and the higher the dose, the higher the efficacious, you know, elements of the medicines. Pretty much all medications when you hire the do you get more effectiveness coming out of it? We have done a trial called Step up with semaglutide at 7.2 milligrams that shows actually weight loss efficacy on par with tris appetite. So my job of course is now to bring that product into the market, the wegovy high dose as soon as possible and basically explain to the world out there that now you have basically similar efficacy on the two fronts, both for us and Lilly. In addition, semaglutide gives you cardio protection, liver protection, kidney protection and then allow the world actually to pick whichever medicine they want. And I do have hope that many more, many more patients this year will get attracted now that the weight loss profile goes higher up with that introduction and they did last year.

[Jim Cramer]

Excellent. That could really cut in your, in your favor. I want to go back to the pill. Eli Lilly tells me, and yes, they're later, it could be as late as April that the pill can be taken any time in the morning. My understanding is there has to be a goodly time between when you take the pill and when you can eat for breakfast your pill. Do you think that people will rebel against that? What happens if you take the pill with breakfast?

[Mike Dewstar]

So 170,000 people this month took the pill and we did not hear a single complaint. So while I 100% understand that our competition has to find their niche and their speaking points and I respect that, my job is to listen to the patients and not listen to what my competition says about my pill. The patients out there have spoken and they've spoken loud that they don't mind when it comes to higher efficacy. They will take basically the higher effect effective product. And to make it even more robust for you, Jim, we have the same pill for diabetic patients called Rebelsis and we've had it in the market for a number of years and we have one and a half million people on it. And the last thing I would hear from these million and a half patients is that the dosing regimen is an issue issue. So I'm very, very optimistic that that is going to be a non issue.

[Jim Cramer]

All right then I've got to circle back, Mike. I listen to what you say about the pill. I listen to what you say about the injection. I listen to what you say about what the patients are saying. And I come to a conclusion that there's just no way you're going to have this shortfall, that there's just no way that this was a correct guide, that you are far too negative, that anyone who is selling the stock right now is making a very big mistake because you may have a substantial superior. Three months. So can you tell me what I'm missing when I say all these good things about the company that is Novo Nordisk?

[Mike Dewstar]

Well, first, I appreciate you recognizing that no company. My. My job, My job is to really make sure I steer Novo Nordisk over a longer period of time. Internally, Jim, I say this is a marathon and not a sprint. Even though every single day we got a sprint on our daily activities. The war and the battles are won in a marathon passion and not in a sprint. My job is to really make sure that when I stand in front of you and say, this is an area that 2 billion people are suffering from and I feel responsible to addressing their unmet need, that I actually find a price point that they can afford it. You and I know very well at the prices that GLP1 was sold not long ago, 2 billion people cannot find that affordability. You have seen when we price our products right, as we did with the pill, how fast the volume uptake is. So my message to you investors myself is be a bit patient. Better days are ahead of us because volume uptake will come on the back of lower prices.

[Jim Cramer]

Well, I do want to just. Just to complete the thought. When I think about the pill and what you just said, that there are no complaints. I had thought that there might be. I think your first mover advantage in the pill is going to be far greater than your first mover advantage that was with the injection because of the changing of how much better Lilly did that. This could be a major game changer because if you are ready with the pill, and that's what I want to know. Are you ready with the pill? Because you may be able to take a huge amount of share in this business and not lose any, which would make me think I got to buy Novo Nordisk.

[Mike Dewstar]

We have. We have been saying that we are ready with the pill from day one. We feel very confident from a supply point of view, which is, unfortunately, the issue we ran into with the injection. We are very comfortable with the pill and the supply level of it, but I also once again remind you there is right now one new pill going to come out soon from Liddy. There's going to be a number of other pills are going to come out. All of these pills, Jim, and you understand the science quite well, all of these pills are small molecule chemical entities. The pill that I'm selling is a large peptide protein encapsulated in a special technology called snack. And that's why it's able to give the same efficacy as its injectable sister, WeGovy injectable. So it's really, really important that we actually recognize this is a different pill than all others.

[Jim Cramer]

Absolutely. Which is once again, why think that your guidance is very conservative. How about that service Mike Do Star. He's the president CEO of Novo Nordisk. Thank you, Mike for coming on the show.

[Mike Dewstar]

Thanks very much, Jim for having me back in.

[Podcast Host/Announcer]

Coming up, after a strong earnings report, Banco Santander is continuing its surge. Now Kramer speaking with the CEO about the Spanish bank's growing plans for its US Footprint.

[Jim Cramer]

Max.

[Podcast Host/Announcer]

Hey, this is Jeff Lewis from Radio Andy live and uncensored.

[Jim Cramer]

Catch me talking with my friends about.

[Podcast Host/Announcer]

My latest obsessions, relationship issues and bodily ailments. With that kind of drama that seems to follow me, you never know what's going to happen.

[Ana Botín]

You can listen to Jeff Lewis live.

[Jim Cramer]

At home or anywhere you are.

[Ana Botín]

Download the SiriusXM app for over 425.

[Jim Cramer]

Channels of AD, free music, sports, entertainment and more. Subscribe now and get 3 months free offer details apply.

[Strauss Zelnick]

Foreign.

[Podcast Host/Announcer]

This episode is brought to you by Schwab Market Update, an original podcast from Charles Schwab. Join host Keith Lansford for this information packed daily market Preview delivered in 10 minutes or less, including projected stock updates, monetary policy decisions and key results and statistics that may impact your trading. Download the latest episode and [e-mail] MarketUpdatePodcast or find Schwab Market Update. Wherever you get your podcasts, CIDP can.

[Jim Cramer]

Make your daily routine feel not so routine. The good news? With a self injection for chronic inflammatory demyelinating polyneuropathy, you have the option to treat at home. Discover [e-mail] and talk to your doctor. That's cidpselfinjection.com brought to you by argenexx. This morning we got excellent full year results from Banco Santander, the Spanish banking powerhouse with a stock that surged 142% over the past 12 months. A bank. We also learned that they're buying Webster Financial. It's a community bank based in Connecticut, Real good one. All part of their plan to dominate the northeastern United States. I think this one's on track to become one of the most profitable banks in the world. Marching steadily towards their goal of 20% return on tangible equity by 2028. Wow. Don't take it from me. Earlier today, we got a chance to speak with team. She's the executive chair of Santander. Take a look. Welcome back to Mad Money.

[Ana Botín]

Hi, Jim, how are you?

[Jim Cramer]

Well, I'm good because once again, you delivered for the people who are in your stock. And by the way, a lot of them got in because it was at 3 and 4 when you started coming on. And now, of course, you have a triple or more. And one of the reasons why you have that I am so impressed. You go for profitability. That's been your mantra and it's working at every country that you're in.

[Ana Botín]

Absolutely. Profitability, being the most profitable bank in each one of our businesses and geographies is our big goal. And obviously we also want to grow. So, yes, profitability and growth.

[Jim Cramer]

There also is a strategy that I think is a little holistic. A lot of people in America, the big banks, they just want rich people. They do. That's how they claim. That's how they make the big money. You go for scale in any other business. If we were doing technology, we know that scale is when your scale has propelled you to be the largest bank in Europe, but possibly soon the largest bank in the world.

[Ana Botín]

So I like to say that we are one of the largest banks in the world by what matters, which is the number of customers. In 2025, Jim, we grew 8 million customers and we're now at 180 million customers. We grew revenues, we had lower cost, and we delivered 17% earnings per share in 25, and we grew capital to 13 and a half. So a very successful year. And yes, we care about growing customers and we believe having a large number of customers is what ultimately reflects on. On a good business. That's why, you know, we grow, because our customers come and join us.

[Jim Cramer]

One of the things that will make you grow rather a little more quickly is this acquisition of Webster in a very wealthy area of the customers are in New York and Connecticut. What made you choose that area? And are there great synergies already so that you can start making even more money once you close that deal?

[Ana Botín]

So the first thing I would say is that it's hard to buy a good bank bank, and Webster is a very good bank. So that is a fundamental criteria for us. Second they have a very complementary business to us. We're in consumer banking, they're in commercial. So together, Webster and Santander will become the fifth largest bank in its footprint, which is the Northeast, and will have an 8% market share, but very importantly, combined will get to 18%. 18% return on tangible equity by 28. That will make us one of the most profitable banks in the United States.

[Jim Cramer]

So tell me, there's something else that you're doing that I think is very exciting. I'm not sure it's going to extend to Webster, but when you speak to young people, they're very much drawn by the fact that you can get 4.2%. Now, you introduced that program on our show. It is, from what I can tell, the highest rate that you can get. Will you be able to open a lot of new accounts in Webster when they see, if you do extend that rate, the Santander rate, would you take it there?

[Ana Botín]

So that is a different part of the bank that's. That's open bank. It's a national digital bank that will continue. That's the auto finance and open bank is across the United States. Webster and Santander retail bank is in the northeast east, and that covers the area, you know, that you know very well, which is an area as big as the United Kingdom. So. So they will have different strategies. Open bank, eventually, you know, the services will be extended to all our customers. But think of the retail commercial bank of Santander bank and Webster in the Northeast and open bank national across the whole United States, together with our auto business.

[Jim Cramer]

Well, people do like the national. The national rate. Now, I want to talk about auto. Some of my friends who are in that business are starting to worry about subprime, starting to worry about the consumer being stretched. Are you doing okay when it comes to keeping originations high and not having credit woes?

[Ana Botín]

So we see the US Consumer very resilient. Yes. You know, things have gotten a bit more difficult at the lower end, but still we're getting very high recovery. So people might take a bit longer, but they end up, you know, paying and being whole. So I would say the US Consumer is overall still doing fine.

[Jim Cramer]

All right. Now, you like to shuffle your.

[Ana Botín]

At least on the other side.

[Jim Cramer]

Okay. Yeah.

[Ana Botín]

On the other side.

[Jim Cramer]

Right. Is the one side on the. That's what I care about. Now you. You do shuffle things. Poland was a country country. That's good. But you kind of double down on the UK and you move yourself from some of Poland. How do you decide where you want to make your big Bets.

[Ana Botín]

So, you know, 25 was a very, very good year for Santander. We met all our targets. We took our rot at the the group level to over 16%. What matters to us is that in the markets where we have a presence, that we have strong network effects, not just within the country, but with the other Santander countries. And Poland didn't have network effects with the rest of the Santander footprint. You know, we got a good offer at 2.2 times book value. We have reinvested that in the UK with TSP, where our shareholders are getting, you know, 20% return on investment of capital, and in the US with Webster, where we have also a 15% return on invested capital. But very importantly, the US has very strong network effects with Latin America. You know, Jim, very well that we're in Mexico, in Brazil, and there is more and more connectivity between the United States and our Latin American banks. And that makes a huge difference. And, you know, that is why we were the best possible buyer for Webster, together with a global scale of our platforms.

[Jim Cramer]

Well, let me ask you, what does it look like worldwide now given the fact that you have 180 million customers and you're in so many different countries? What is the. What is when people go to Davos, say, well, they kind of have a view, but it's all very anecdotal. You have an empirical view. What is the view from where you sit about how the world is doing?

[Ana Botín]

So the Santander world, which is Europe and the Americas overall looks better in 26 than it did in 25. There is a lot of uncertainty, obviously. Valuations, markets, all the things we know. But if you look at where we expect in a base case, growth, unemployment, inflation, the US looks better. Spain looks at least as good, more or less as last year. Those are two big markets for us. Brazil will slow down a bit, Latin America, but still with growth. So, you know, I'd say solid growth, not great, but solid growth. Inflation either stable or coming down and unemployment holding at quite high levels. Those are the things that we in the banks, you know, and I think most people would look at and they look pretty good.

[Jim Cramer]

Well, I want to leave it on that because I think it's a terrific note to do. So that's Anna Boutine. She's the bank of Sandair executive chair. And what a stock. Much better than any of the performance of any our banks. Thank you so much.

[Ana Botín]

Thank you, Jim.

[Jim Cramer]

Yeah. But even back it coming up are.

[Podcast Host/Announcer]

Investors underrating Take two Interactive Cramers connect with the company's CEO to find out if the stock is about to level up next.

[Jim Cramer]

All right, here we have an old friend and a great stock too. Last time we got results from Take Two Interactive Software. That's the big video game publisher. The actual quarter was solid. The full year forecast terrific. And they got Grand Theft Auto 6 coming out in November. But the stock still lost more than 5% today. And that's on top of a brutal decline earlier this week. Unfortunately, Take Two reported just as everybody's freaking out about Google's Project Genie and a platform that seems like you can create video games out of whole cloth. You know what? I think this may be the last great buying opportunity before. Okay, let's say that for a second. Let's check in with Charles Zelda. He's the chairman and CEO of Take to Interact, by the way, who has never led us astray. That is very difficult in a 21 year existence. Questions? Mr. Zotic, welcome back to bed.

[Strauss Zelnick]

Great to be here, Jim.

[Jim Cramer]

Okay, so Strauss, first I want to just tackle something hit on. Let's say that I were to develop a really terrific video game and I did it on Google, the Genie and I put it in YouTube. How much money would I make?

[Strauss Zelnick]

Look, there are examples of independent developers doing really well. And, and that's great because creator content sets aside professional content. It's a small business, but it's a business now and then, but very selectively.

[Jim Cramer]

Okay.

[Strauss Zelnick]

The truth is it's really hard to do and really hard to market, of course.

[Jim Cramer]

And those are what matter. And tell me, of the 20 video game companies that are left, you're the only independent left. Where they.

[Strauss Zelnick]

Well, assuming the deal closes, will be the largest public name Pure Play.

[Jim Cramer]

I look at it like this. If I were using that and I had a really great one, I'd be knocking down your door in order to. To be able to get your distribution.

[Strauss Zelnick]

System and the marketing dollars that we can put behind a product and the risk that we can take.

[Jim Cramer]

Okay, I just want to put that out there because business people who heard that would say, you know what, this is really not the end of Take Two. And if anything, Take two actually could be a beneficiary.

[Strauss Zelnick]

I mean, that's the key point. The key point is that our business has availed itself with machine learning and artificial intelligence since the beginning. We make our games in computers. New technology is great for us. We have hundreds of AI projects going on now it Take Two in our subsidiaries. This is a good thing. We're already driving efficiencies and it's already helping us with creativity. You can't confuse tools with entertainment properties. They're different things.

[Jim Cramer]

Now I know that. You know who explained that to me first time? Jensen Wong. When he talked about ray tracing, I said who's using it? Said well the only people really know how to use a Take two and because he's a gamer and he knows.

[Strauss Zelnick]

Me about it very early on, yes.

[Jim Cramer]

Now he's a gamer. Now I do want to talk about things that do matter. Okay. For instance, before we get to GTA launch, mobile strength. Really incredible.

[Strauss Zelnick]

Yeah, we're up 19% year over year and it's really across the board. It's our legacy games like tomblast up 43% year over year, empires and puzzles 11%, words with friends 6% and then new hits Match Factory and Color Block Jam. And it's really hard to to create new hits in mobile. Our teams have been able to do that over and over again. It's been a great accretive transaction for us.

[Jim Cramer]

And there was a time when you were kicking yourself you didn't have anything in the category and you told me you knew the category was big.

[Mike Dewstar]

Right.

[Strauss Zelnick]

And it is the fastest growing part of the interactive entertainment business.

[Jim Cramer]

Okay, now NBA 2K. Some things just don't run out. Do that.

[Strauss Zelnick]

If you keep doing great stuff, the work has to get better and better. Visual Concepts, which is the label that makes NBA 2K inside the 2K label just sets the bar higher and higher every year. We're up 30% year over year. We've sold in 8 million units and it is of course the biggest selling sports game in North America.

[Jim Cramer]

Now before we get to gta, tell us what else is has part of the library that you actually have kind of paid for that is still making a lot of money.

[Strauss Zelnick]

Well, our, our catalog alone generates, I don't know, 35% of our net bookings year in year out. That the gift that keeps on giving.

[Jim Cramer]

Right.

[Strauss Zelnick]

But the titles at 2K include Borderlands, Borderlands 4 just came out, Civilization 7 came out, the Bioshock franchise and many others in addition to WWE 2K, the PGA Tour title and of course NBA 2K. I mentioned some of our mobile hits and there are many more to come. We also have top 11, a lot of other great titles. And even at the Rockstar label, it's not just about gta. Red Dead continues to be Red Dead, you know, huge contributor to our earnings. So we have Frontline new intellectual property, frontline properties that are sequels, a lot of those. And then we have a big catalog and then of course, live services.

[Jim Cramer]

All right, now let's, let's talk about the greatest entertainment vehicle of all time. Is that definitely.

[Strauss Zelnick]

I think that's true, yes.

[Ana Botín]

Right.

[Jim Cramer]

There's nothing that comes near when the. I got the earnings. The first thing I did was go and check the date because I know that you're not going to release something until it's perfect. And I wanted to be sure that this November date is still November 19th. Now how do you know? How do you know it's going to be ready that day?

[Strauss Zelnick]

Well, because we actually obviously track progress daily of everything that we do. And we also announced that we have marketing beats coming this summer. We don't spend money on marketing until we're pretty close to release.

[Jim Cramer]

Do you really need to spend money on marketing on what I think is one of the greatest word of mouth products in history?

[Strauss Zelnick]

We do. I think there, there's a difference in between awareness and energy. And we need to create the energy we do have. The awareness, the anticipation is huge. It's, it's bigger than ever before. But in our business you do have to tell people what's coming. And our consumers want to know that this is going to be great and they want to see what the visuals look like. It is a challenge because we want the product to be authentically owned by our consumers. And so the marketing has to be delicate. It has to feel like, you know, this is real, this is not. We're not selling hamburgers, we're selling this unique art form.

[Jim Cramer]

Now one last question and it's right along those lines. Jensen told me that sometimes you need to upgrade your equipment in order to be able to deal with the greatest stuff that you're doing. Will there need to be an upgrade cycle just to be able to do GTA?

[Strauss Zelnick]

Well, we're launching GTA 6 on the, on the newest consoles. Those consoles have been in market for some time, so some people who don't have those consoles might have to buy them and I think will probably energize console sales. But no, the technology is in market. Right.

[Jim Cramer]

I actually thought about telling people to buy Best Buy because of this. There's other problems with Best Buy, but yes, I think there's going to be upgrade cycle. That's much better than say the co pilot up.

[Strauss Zelnick]

Quite so I again, I think there's a lot of energy around this property.

[Jim Cramer]

Excellent.

[Strauss Zelnick]

Fingers crossed.

[Jim Cramer]

Well, I got to tell you, it's great to have you back, Strauss. You just, you just have built an amazing company. I know you'll credit many people to say I'm fortunate.

[Strauss Zelnick]

I have this amazing team. The best creative talent in the business. The best executive talent the business.

[Jim Cramer]

Okay, that's Strauss. He's the chairman CEO of take to interactive and yes I do think that you're getting a chance to buy it that actually I didn't get with a car that money's back there for.

[Podcast Host/Announcer]

Coming up Kramer takes your calls and the sky's the limit. It's a fast fire lightning round next.

[Jim Cramer]

It is time. It's time for the light round Christmas round of course in the stocks. Bye bye bye. My step first play where you planet sound and then the lightning round is over. Are you ready? With Michael in Washington. Michael. Michael.

[Caller/Viewer]

Hello?

[Jim Cramer]

Hey, it's Kramer. What do you got my friend? Yeah, it's Kramer. What's happening?

[Caller/Viewer]

Yeah, I believe the recent gold sell off presents a rare buying opportunity in the miners which report soon and should see unusually high margins cash flows and profits. Since gold prices are up sharply over the quarter and costs were down due to cheap oil and air productivity. I own lots of Agnico Eagle, the premier firm and I'm now looking at Newmont which last no need you on the best.

[Jim Cramer]

You are the best owner bullion other than that and I think you'll be fine. I need to go to Peter. New York Peter. Booyah.

[Caller/Viewer]

Jim, how are you?

[Jim Cramer]

I'm not bad for you. Good.

[Caller/Viewer]

I'm waiting for the last new copy of your book from ebay.

[Jim Cramer]

Oh, there you go. I love that. Thank you, Jim.

[Caller/Viewer]

This pharmaceutical company is trading at 6 over $6 today. Their annual revenue is about 600 million and a recent net loss of about 9 million. Is the current price at discount on its rare disease pipeline or has the market already factored in expectations for the future performance Biocrest Pharmaceuticals bcrs.

[Jim Cramer]

No, just stay away from that. I mean honestly that's. It's just been a very bad stock dome for a very long time and I don't think it's going to improve. I need to go to Pete now in Alaska. Pete. Booyah.

[Caller/Viewer]

Jim from Anchorage, Alaska, my friend, you need to get up here and do some fishing.

[Jim Cramer]

I completely agree with that. I did. I did combat fishing up there once. It was fantastic. It was very very relaxing. Oh yeah, Combat. Hey making this really quick.

[Caller/Viewer]

So I've got a position and I'm looking to increase. Just want to know your opinion on continue to hold or buy NXT Next Power formerly Next Tracker.

[Jim Cramer]

All right, that's suge. Dan Sugar. Dan Sugar. We actually own it for the trust we sold it too soon. He is a money maker. Just go buy it. That's how good he is. Just go buy it. I love that guy. Let's go to John in New Jersey. John. Hello, Mr. Kramer. How you doing? John, I would value your opinions on Skywest Incorporated. I buy United and I buy FedEx. And you get them both. Okay, let's go to Kevin. Oh, I'm not. I am so not done. I am so fired. Let's stop that right now. Let's go to Kevin in Massachusetts. Kevin. Hey, Jim. Booyah. I really enjoy the show.

[Caller/Viewer]

I wanted to know your take on.

[Jim Cramer]

Synchrony financials Ticker Sy. I don't want to own synchrony. I want to own capital one cof the chapel trusted. It's pulled back nicely from 259 to 225. Now we're going to go to Kenny in New York. Kenny.

[Caller/Viewer]

Hey, Mr. Kramer, thank you so much for taking my question.

[Jim Cramer]

You bet.

[Caller/Viewer]

All right, so I purchased EOS Energy Enterprises last year and was happy with it until now. What's going on with that stuff?

[Jim Cramer]

I mean, it's just the kind of classic. That's a year of magical thinking, magical investing stock. We don't want to touch that one. But it is in Edison, New Jersey, which is where, by the way, Edison was born. It just happens to be a great coincidence. And that. Ladies, conclusion of the Lightning Round.

[Podcast Host/Announcer]

The Lightning Round is sponsored by Charles Schwab. Coming up. For years, companies of coders have dominated. But could their era be coming to an end? Kramer's revealing why he thinks it's time to pull the plug on them.

[Jim Cramer]

Next. When I got out of school, the goal was pretty simple. Get a job at Goldman Sachs. I did it for the same reason that will be Sutton. Rob banks. That's where the money is. Goldman Sachs was a smorgasbord of greatness. You go into equities trading, securities sales, fixed income, the bond market, munis, M and A. And then the mack daddy of all corporate finance. With all those deals to be done, incredibly lucrative big money without being flashy. Goldman Sachs is still an amazing firm. But about 30 years ago, the big money move gravitated to private equity. At KKR Blackstone Carlyle, you could take underperforming companies private, then fix them up, sell them back to the public at a fantastic markup. It wasn't easy to work at these private equity firms, but if you got the job, oh boy, you could make fortunes. Then around the turn of the century, the big money moved west. People could start their own companies if they knew how to code. And this was a business that regularly created billionaires. The smartest coders created companies that could help other businesses do everything better. Anyone who knew how to write code was an incredibly valuable commodity. The coders quickly learned to meet with venture capitalists who fortunes into them before eventually flipping them to the public for even bigger fortunes. Like McDonald's. Billions and billions sold. The great thing about these enterprise software companies back during the heyday, they didn't have to make money. They just needed rapid revenue growth. Investors couldn't get enough of them and the coders made vast fortunes. It was a bonanza. Stock based compensation is a wonderful thing unless you're a shareholder. But all bonanzas do come to an end. And the enterprise software bonanza seems to have run its course. That's what's going on in the market today. Why? Because of artificial intelligence? With AI you don't need programmers because these platforms can write code better than humans. I should have realized that someone was getting displaced the first time. Nvidia's Jensen Huang had me speak into a machine and out came what I wanted. A Cezanne, Seascape, Shakespeare, Shakespeare's Globe Theater, Star Wars, Stormtroopers. There were no secret coders behind the curtain. Suddenly it seems like those coders with their expensive wares won't be needed anymore. No more golconda for these guys. Late last week, an alpha called Anthropic released a number of new AI tools to help professionals in various industries. They're going to save businesses. Fortune. Sales, finance, legal, hr, it, marketing. All at the expense of third party software software vendors. It's still early days, but I think Anthropic can find all sorts of ways for businesses to save money by getting rid of expensive coders. It could be a coding apocalypse. And that's why all the enterprise software stocks are coming back to earth. When you look at the iShares Expanded Tech Software Sector ETF, the median price to earnings multiple for the profitable companies in this thing has shrunk from 28.4 times earnings at the end of 2024 to less than 21 times earnings today. That's a new land speed record for multiple compression. It's because investors think it's just a matter of time before an Anthropic or an open air crushes the entire industry that these prices are coming down. Now I am simplifying here. There are plenty of software companies that are unique enough to avoid this fate. Many of them will benefit from using AI tools themselves. But the money will no longer be as bountiful. The IPOs they could be still warm. The big money is moving on from enterprise software right now in the stock market. That cash has been flowing in part to companies that should now be able to save by not spending on expensive software and coding. Maybe they will use AI and this revolution is happening right in front of your eyes. Be ready. The enterprise software stocks can bounce. It will bounce, probably, but they may never be worth what they once were because maybe they never should have been trading that high to begin with. I like to say there's always bull market. So promise I'll find it just for you or your man Money. I'm Jim Cramer. See you tomorrow.

[Various Advertisers/Voiceover]

All opinions expressed by Jim Cramer on this podcast are solely Kramer's opinions and do not reflect the opinions of CNBC or its parent company or affiliates, and may have been previously disseminated by Kramer on television, radio, Internet or another medium. You should not treat any opinion expressed by Kramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Kramer's opinions are based upon information he considers reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full Mad Money disclaimer, please visit cnbc.com madmoneydisclaimer this is Rich.

[Podcast Host/Announcer]

Gannon from SiriusXM NFL Radio reminding you that Sirius XM is the place to hear every NFL playoff game from the Wild Card Round all the way through the Super Bowl. Plus you get to decide how you want to listen to the game. We'll have the hometown announcers for each game and the national broadcasters on your radio and on the SiriusXM app. And if it's football talk that you want, just search for NFL Radio on the app or tune to Sirius XM channel 88 in your car.